Evidence map›Paper›PMID 41754167›Full record

ArticleNutrients2026

A Multi-Target Phytotherapeutic Approach to Benign Prostatic Hyperplasia: Preclinical Characterization of a PhytoBPH-Mix.

Chiara Amante, Chiara De Soricellis, Maria Rosaria Sellitto, Giovanni Falcone, Luigi Luccheo, Gianni Luccheo, Pasquale Del Gaudio

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chiara AmanteDepartment of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, SA, Italy.ORCID 0000-0002-2906-6500
Chiara De SoricellisDepartment of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, SA, Italy.ORCID 0009-0009-0777-2066
Maria Rosaria SellittoDepartment of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, SA, Italy.
Giovanni FalconeDepartment of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, SA, Italy.ORCID 0000-0003-1237-7350
Luigi LuccheoAnvest Health s.r.l., Via Rosario Livatino, 84083 Castel San Giorgio, SA, Italy.
Gianni LuccheoAnvest Health s.r.l., Via Rosario Livatino, 84083 Castel San Giorgio, SA, Italy.ORCID 0009-0003-4870-2060
Pasquale Del GaudioDepartment of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, SA, Italy.ORCID 0000-0003-3852-4523

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PhytotherapyPlant ExtractsProstatic Hyperplasia5-alpha Reductase InhibitorsAnimalsAnti-Bacterial AgentsAnti-Inflammatory AgentsEpilobiumEscherichia coliHumansLycopeneMaleSerenoaTumor Necrosis Factor-alphaUrtica dioicaVitamin E5-alpha Reductase InhibitorsAnti-Bacterial AgentsAnti-Inflammatory AgentsLycopenePlant ExtractsTumor Necrosis Factor-alphaVitamin Ebenign prostatic hyperplasialower urinary tract symptoms (LUTS)phytotherapeuticPygeum africanumSerenoa repens

Identifiers

PMID41754167
PMCPMC12943485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.